SARAH COLLINS: Open Payments
NPI 1548514177 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 69 payments from 18 companies in 2025. Trend: 2023 $1,017 · 2024 $656 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $295 |
| Otsuka America Pharmaceutical, Inc. | 15 | $226 |
| PFIZER INC. | 6 | $162 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| ABBVIE INC. | 5 | $90 |
| Novo Nordisk Inc | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Lundbeck LLC | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
Products named: CAPLYTA, REXULTI, ELIQUIS, Auvelity, TRELEGY ELLIPTA, VRAYLAR, COBENFY, Wegovy.
Industry payments across MI — which companies pay providers there.
